Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 2-hours post l-phe supplementation
Awards & highlights
No Placebo-Only Group
Summary
This trial studies how an amino acid supplement affects mental health and cognition among people with and without a genetic disorder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Blood Pressure
Individual Coefficient of Variance (Variability in Reaction Times)
Mood
+2 moreOther study objectives
Chronic Anxiety
Chronic Depression
Impulsivity
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Genetic Carriers and Non-Carriers of PKUExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of GuelphLead Sponsor
83 Previous Clinical Trials
14,988 Total Patients Enrolled
McMaster UniversityOTHER
916 Previous Clinical Trials
2,615,218 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently taking a certain type of antidepressant called Monoamine Oxidase Inhibitor (MAOI).You have been diagnosed with PKU (phenylketonuria).You have been diagnosed with serious brain diseases that affect memory and thinking, like Alzheimer's or Parkinson's disease.
Research Study Groups:
This trial has the following groups:- Group 1: Genetic Carriers and Non-Carriers of PKU
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger